Columbia University AL Amyloidosis Recent Advances In The Diagnosis & Treatment 2024
Format: 7 videos + 11 pdfs, size: 2 GB
Course Audience: pathologists, cardiologists, nephrologists, immunologists, oncologists
Overview:
Columbia University Irving Medical Center invites you to join the leading educators from Columbia University, addressing an overview of high yield challenging scenarios in the management of AL Amyloidosis. Through a combination of lectures and case-based presentations, this course will deliver up-to-date and cutting-edge information that can be directly integrated into clinical practice.
Learning Objectives
-Clinical presentation, diagnostic methods and risk stratification of patients with newly diagnosed systemic AL Amyloidosis.-Management of patients with newly diagnosed systemic AL Amyloidosis.-Management of various organ involvement such as heart failure and nephrotic syndrome, autonomic neuropathy and GI involvement in patients with AL Amyloidosis.-Discuss and develop consensus in guidelines for managing relapsed and refractory cases, including the role of salvage therapies and experimental approaches.This event is designed for a diverse group of healthcare professionals involved in the diagnosis and treatment of AL amyloidosis. The target audience includes:
Physicians
Nurse PractitionersPhysician AssistantsNursesPharmacistsAllied Healthcare ProfessionalsThis course aims to provide up-to-date and cutting-edge information that can be directly integrated into clinical practice through a combination of lectures and case-based presentation.